MED
Get informed when a big investor buys or sells
+ FollowUndervalued by 263% based on the discounted cash flow analysis.
| Market cap | $140.32 Million |
|---|---|
| Enterprise Value | $101.29 Million |
| Dividend Yield | $6.59 (-) |
| Earnings per Share | $-1.7 |
| Beta | 0.68 |
| Outstanding Shares | 11,135,000 |
| P/E Ratio | -5.42 |
|---|---|
| PEG | 2.41 |
| Price to Sales | 0.41 |
| Price to Book Ratio | 0.68 |
| Enterprise Value to Revenue | 0.32 |
| Enterprise Value to EBIT | -6.34 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.17 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0128▼ 2.23% |
|---|---|
| Total Calls | 125,200▼ 92.17% |
| Total Puts | 1,600▼ 97.15% |
Holdings and activity of institutional investors.
| Ownership % | 11.85%▼ 66.31% |
|---|---|
| Total Invested | $13.84M▼ 84.20% |
| Investors Holding | 41▼ 79.00% |
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...